Brought to you by 
Great Basin nets $7.4mm via IPO
10 Oct 2014
Executive Summary
Great Basin Corp. (infectious disease diagnostics) netted $7.4mm through the initial public offering of 1.15mm units at $7. Each unit consists of one share of common stock and a one-year Series A warrant; the Series A warrant is exercisable for one common share at the IPO price and one Series B warrant, also exercisable for one share. (The Series B warrants will only be issued upon exercise of the Series A warrants, and are then exercisable for six years at 125% of the IPO price.)
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Great Basin nets $7.4mm via IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice